Search results
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
Benzinga via Yahoo Singapore Finance· 5 hours agoOn Thursday, Agios Pharmaceuticals Inc (NASDAQ:AGIO) released topline results from the global Phase...